Edick, 68, who took the reins at Xeris in 2017, will retire from his day-to-day role and the company chairmanship, Xeris said ...
The clinic will provide two medications that can slow the progression of the disease in early stages: Leqembi and Kisunla.
The U.S. Food and Drug Administration on Tuesday approved another drug that slows cognitive and functional decline in people ...
Just as a new Alzheimer's drug comes on the market, South Carolina bike riders will brave 255 hot miles across the state to ...
There’s no cure for Alzheimer’s disease, but in the past few years, researchers have found treatments that seem to stop some ...
I’m so excited that we have something that actually possibly could lead to a cure. There is no cure yet. But we’re really ...
Lilly’s drug that can slow Alzheimer’s disease has received the approval of the U.S. Food and Drug Administration; the ...
On Tuesday, the Food and Drug Administration (FDA) approved Kisunla (donanemab-azbt) injection for the treatment of Alzheimer ...
Click here to get the story. 3. FDA approves new drug for Alzheimer’s disease Eli Lilly’s Kisunla (donanemab) is a monthly injection for adults with early symptomatic Alzheimer’s disease. Doctors ...
In Tennessee, there are more than 129,000 people aged 65 and older with the disease. The FDA recently approved a second drug ...
Chances are you or someone you know has been impacted by Alzheimer's disease. This week, the FDA approved a new drug that can ...
Doctors at the Roskamp Institute aim to treat around 10,000 patients a year with the new drugs and provide resources to area ...